ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   
 Top Breaking News
 Friday, August 22, 2014

San Diego Startup, Hera Therapeutics, Unveils Drug For Viral Infections Tied To Cervical Cancer

FDA Approves Use Of Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis To Treat Leg, Lung Clots

Look Out Auxilium Pharmaceuticals (AUXL), BioSpecifics Technologies Corporation (BSTC) Also Touts Positive Data From Phase 2a Study Of CCH For Cellulite

Update: OncoGenex Pharmaceuticals Inc. (OGXI) Phase 3 ENSPIRIT Trial Continuing As Planned

Auxilium Pharmaceuticals (AUXL) Drug Found Effective Against Cellulite In Phase 2 Study

Ebola-Like Virus Beaten By Tekmira Pharmaceuticals Corporation (TKMR) Drug In Study

FDA Finds Falsified Data, Serious Mold, And Decaying Frogs At Amanta (Formerly Known As Marck Biosciences)

Amicus Therapeutics, Inc. (FOLD) Rockets On Positive Phase 3 Study Data For Rare Disease Drug

More News



 Yesterday's Most Popular News 
Auxilium Pharmaceuticals (AUXL) Drug Found Effective Against Cellulite In Phase 2 Study

Ebola-Like Virus Beaten By Tekmira Pharmaceuticals Corporation (TKMR) Drug In Study

FDA Finds Falsified Data, Serious Mold, And Decaying Frogs At Amanta (Formerly Known As Marck Biosciences)

Amicus Therapeutics, Inc. (FOLD) Rockets On Positive Phase 3 Study Data For Rare Disease Drug

Eli Lilly and Company (LLY)'s Psoriasis Drug Ixekizumab Succeeds In Late-Stage Studies

Popular Antibiotic Linked To Increased Heart Risk, British Medical Journal Reveals

GlaxoSmithKline (GSK)'s Asthma Treatment Wins FDA Approval

Dr. Reddy's Laboratories, Inc. (RDY)'s Breached Packaging Rules: U.S. Regulator

Why Older People Have Trouble Sleeping, Beth Israel Medical Center And University of Toronto Reveal

Young Blood To Be Used In Ultimate Rejuvenation Trial, Stanford University Reveals


 
-

 Featured Stories
 

  Today's Top Jobs

 Featured Employer
About Genzyme Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis. Learn more at www.jobsatgenzyme.com. Follow our jobs on Twitter www.twitter.com/genzymejobs. Follow us on LinkedIn http://www.linkedin.com/company/genzyme. About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Show me jobs for this employer

 Careers
 
More Career Tips